drugset / Trial / NCT02719158

Dose Ranging Study of OTO-201 in AOMT

NCT02719158

Phase 2 Completed 95 enrolled Otonomy, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Dose Ranging Study of OTO-201 in AOMT

Timeline

Start
2016-02
Primary completion
2016-06
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 6 mg Other
Subject Ciprofloxacin Small molecule 12 mg Other

Indications